HRS-8427
HRS-8427 is a pharmaceutical drug with 5 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 3 completed trials
Phase Distribution
Phase Distribution
3
Early Stage
1
Mid Stage
1
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
100.0%
3 of 3 finished
0.0%
0 ended early
2
trials recruiting
5
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Pharmacokinetics Impact of HRS-8427 on Bupropion and Midazolam in Healthy Subjects
Pharmacokinetics and Safety of HRS-8427 in Healthy Volunteers and in Patients With Impaired Renal Function
Study on the Mass Balance of [14C]HRS-8427 for Injection in Healthy Chinese Subjects
A Trial of HRS-8427 in the Treatment of Adults With Bacterial Pneumonia
A Trial of HRS-8427 in the Treatment of Adults With Complicated Urinary Tract Infection, Including Acute Pyelonephritis
Clinical Trials (5)
Pharmacokinetics Impact of HRS-8427 on Bupropion and Midazolam in Healthy Subjects
Pharmacokinetics and Safety of HRS-8427 in Healthy Volunteers and in Patients With Impaired Renal Function
Study on the Mass Balance of [14C]HRS-8427 for Injection in Healthy Chinese Subjects
A Trial of HRS-8427 in the Treatment of Adults With Bacterial Pneumonia
A Trial of HRS-8427 in the Treatment of Adults With Complicated Urinary Tract Infection, Including Acute Pyelonephritis
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5